Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, et al
"I think this still is going to have a significant role." The results of a phase 3 clinical trial found orforglipron delivered "significant weight loss" compared to a placebo in adults with obesity or overweight and Type 2 diabetes, and a "meaningful" reduction in A1C (a test used to measure blood sugar levels), Eli Lilly noted in a statement
Both irritate the gut and slow digestion, so drinking intensifies nausea and reflux and raises dehydration and low blood sugar risk, more so with diabetes meds
Its closely related to GHK-Cu (copper tripeptide-1, CAS 89030-95-5) but is a synthetic peptide designed specifically for hair follicle cells
Cardiovasc Ther